Loss of the Drosophila cell polarity regulator Scribbled promotes epithelial tissue overgrowth and cooperation with oncogenic Ras-Raf through impaired Hippo pathway signaling
© Doggett et al; licensee BioMed Central Ltd. 2011
Received: 21 March 2011
Accepted: 29 September 2011
Published: 29 September 2011
Epithelial neoplasias are associated with alterations in cell polarity and excessive cell proliferation, yet how these neoplastic properties are related to one another is still poorly understood. The study of Drosophila genes that function as neoplastic tumor suppressors by regulating both of these properties has significant potential to clarify this relationship.
Here we show in Drosophila that loss of Scribbled (Scrib), a cell polarity regulator and neoplastic tumor suppressor, results in impaired Hippo pathway signaling in the epithelial tissues of both the eye and wing imaginal disc. scrib mutant tissue overgrowth, but not the loss of cell polarity, is dependent upon defective Hippo signaling and can be rescued by knockdown of either the TEAD/TEF family transcription factor Scalloped or the transcriptional coactivator Yorkie in the eye disc, or reducing levels of Yorkie in the wing disc. Furthermore, loss of Scrib sensitizes tissue to transformation by oncogenic Ras-Raf signaling, and Yorkie-Scalloped activity is required to promote this cooperative tumor overgrowth. The inhibition of Hippo signaling in scrib mutant eye disc clones is not dependent upon JNK activity, but can be significantly rescued by reducing aPKC kinase activity, and ectopic aPKC activity is sufficient to impair Hippo signaling in the eye disc, even when JNK signaling is blocked. In contrast, warts mutant overgrowth does not require aPKC activity. Moreover, reducing endogenous levels of aPKC or increasing Scrib or Lethal giant larvae levels does not promote increased Hippo signaling, suggesting that aPKC activity is not normally rate limiting for Hippo pathway activity. Epistasis experiments suggest that Hippo pathway inhibition in scrib mutants occurs, at least in part, downstream or in parallel to both the Expanded and Fat arms of Hippo pathway regulation.
Loss of Scrib promotes Yorkie/Scalloped-dependent epithelial tissue overgrowth, and this is also important for driving cooperative tumor overgrowth with oncogenic Ras-Raf signaling. Whether this is also the case in human cancers now warrants investigation since the cell polarity function of Scrib and its capacity to restrain oncogene-mediated transformation, as well as the tissue growth control function of the Hippo pathway, are conserved in mammals.
Drosophila has long been recognized as an important model organism for elucidating oncogenic and tumor suppressor pathways [reviewed in ]. Traditionally two distinct classes of tumor suppressor mutants have been described, the loss of which cause either hyperplastic or neoplastic overgrowth [reviewed in ]. Hyperplastic overgrowth is characterized by excessive cell proliferation that is eventually restrained by terminal differentiation, while neoplastic overgrowth exhibits impaired differentiation, defects in cell polarity and the propensity to invade and metastasize.
Over recent years, a large number of hyperplastic tumor suppressor mutants have been united into a single pathway, the Hippo pathway [reviewed in ]. Core components of the Hippo pathway include the serine-threonine kinases Hippo (Hpo) and Warts (Wts), and their adaptor proteins, Salvador (Sav) and Mob-As-Tumor-Suppressor (Mats). Hpo phosphorylates and activates Wts, and Wts phosphorylates and thereby inactivates the transcription co-factor Yorkie (Yki). Loss of Hippo pathway components leads to reduced phosphorylation of Yki and its translocation to the nucleus where it binds to its DNA binding partner, Scalloped (Sd), and promotes expression of proteins involved in cell proliferation (Cyclin E; CycE), cell growth (Myc) and cell survival (Drosophila Inhibitor of Apoptosis 1; DIAP1) [4–11]. It is the dual role of the Hippo pathway in regulating both cell proliferation and survival functions that makes its loss such a potent driver of tissue overgrowth. The pathway is regulated through input from upstream components including Merlin and Expanded (Ex), and the transmembrane proteins Fat (Ft) and Dachsous (Ds) [12–19]. It is proposed that the primary function of the Hippo pathway is to incorporate positional cues within an epithelial field to dictate the ultimate size of organ development . The pathway is highly conserved and also functions to restrain organ size in mammals. Furthermore, increasing evidence links Hippo pathway deregulation to tumorigenesis [reviewed in ].
In contrast to the hyperplastic Hippo pathway mutants, mutants that result in neoplastic overgrowth are characterized by alterations in cell polarity and a failure to terminally differentiate. Neoplastic mutants include the junctional scaffolding genes that regulate cell polarity, scrib, discs large (dlg) and lethal giant larvae (lgl), as well as mutants within the endocytic pathway including avalanche (avl), tumor suppressor protein 101 (TSG101) and Rab5 [reviewed in ]. The loss of apico-basal cell polarity and overgrowth phenotypes of a number of these mutants, including scrib, lgl, avl and TSG101 are dependent upon atypical protein kinase C (aPKC) activity, since mutant phenotypes can be rescued by reducing atypical protein kinase C function [23–25]. Direct and mutual antagonism between the junctional tumor suppressors and aPKC has been demonstrated by the ability of aPKC to associate with and phosphorylate Lgl, thereby releasing Lgl from the cell cortex and thus potentially inhibiting Lgl function , and the ability of Lgl to inhibit aPKC-dependent phosphorylation of other key targets . Like the Hippo pathway, mammalian homologues of the Drosophila neoplastic tumor suppressors, as well as aPKC, are increasingly implicated as important players in human cancers [reviewed in ].
It is now becoming apparent that these two formerly separate classes of hyperplastic and neoplastic tumor regulators are interconnected. Indeed, wts mutants were originally identified based upon mutant cell morphology , and this is now known to be a phenotype associated with other Hippo pathway mutants and due to Yki-dependent upregulation of the apical cell polarity determinant Crumbs (Crb) and apical hypertrophy [30, 31]. Crb itself acts to regulate Hippo signaling by binding to Ex , and either excessive Crb activity or loss of Crb results in deregulation of Ex and an impairment to Hippo signaling resulting in tissue overgrowth [32–35]. The neoplastic tumor suppressors scrib, dlg and lgl also interact with the Hippo pathway. dlg, lgl or scrib mutant follicle cells surrounding the female ovary have elevated levels of Yki targets Cyclin E and DIAP1, and exhibit strong genetic interactions with wts . Furthermore, loss of lgl has been shown to impair Hippo signaling in the eye disc in an aPKC signaling-dependent manner . Indeed in the wing disc both the loss of lgl or ectopic aPKC activity promotes Yki activity through an upregulation of Jun N-terminal kinase (JNK) signaling . Whether scrib regulates the Hippo pathway in the eye or wing disc is not yet clear. In contrast to lgl, reduced levels of Scrib in the eye disc to levels where apico-basal cell polarity is only mildly affected does not impair Hippo signaling , although prior studies with null alleles have demonstrated both aPKC-dependent proliferation as well as ectopic JNK signaling in scrib mutant eye disc clones . Furthermore, whilst homozygous scrib mutant wing disc overgrowth is reduced in response to limiting Yki levels , it has not been determined if Hippo signaling is impaired in this tissue and whether the genetic interaction with yki reflects a general sensitivity of scrib mutant tissue to limiting levels of survival/proliferation functions. Clarifying the relationship between scrib and the Hippo pathway is therefore required.
In this study, we show that loss of scrib promotes eye and wing disc epithelial tissue overgrowth, as well as cooperative neoplastic overgrowth with oncogenic Ras-Raf signaling, through impaired Hippo pathway signaling. Significantly, despite JNK signaling being activated in the absence of scrib, the Hippo pathway remains impaired even when JNK is blocked. In contrast, Hippo pathway deregulation in scrib mutants is dependent upon aPKC signaling, and ectopic activation of aPKC is sufficient to downregulate the Hippo pathway independent of JNK signaling. As both the Scribble cell polarity module and the Hippo pathway are conserved in mammals, and loss of apico-basal cell polarity is a hallmark of mammalian epithelial neoplasias, it is likely that our results have significant implications for human tumorigenesis.
scribmutant eye disc cells exhibit impaired Hippo pathway signaling, and this does not require JNK signaling
We have previously reported that scrib mutant clones of tissue in the eye disc exhibit ectopic CycE expression and excessive cell proliferation, although this is restrained through JNK-dependent apoptosis . If JNK signaling is blocked in scrib mutant clones by expressing a dominant negative version of Drosophila JNK, bsk (bsk DN ), apoptosis is prevented and mutant cells are observed to ectopically proliferate posterior to the morphogenetic furrow (MF) resulting in clonal overgrowth . The ectopic cell proliferation in scrib mutant clones expressing bsk DN is similar to mutants in the Hippo pathway, and therefore to determine if the Hippo pathway is impaired by the loss of scrib, we examined known targets of Hippo-mediated repression in scrib mutant eye disc clones. Targets examined included protein levels of DIAP1 , and expression of the enhancer traps for four-jointed (fj-lacZ) and ex (ex-lacZ), both of which are known to function as readouts of impaired Hippo signaling [17, 41].
The bsk DN transgene is highly effective at blocking JNK signaling since it completely abrogates both the ectopic expression of the JNK pathway reporter, msn-lacZ, and the JNK pathway target, Paxillin, in scrib mutant clones . However, to confirm that JNK signaling was not required for Hippo pathway impairment, we also knocked down bsk expression in scrib mutant cells using a bsk RNAi transgene. Like the expression of bsk DN in scrib mutant clones, this resulted in pupal lethality and in the formation of larger clones of scrib mutant tissue in the eye disc, suggesting that cells were no longer dying. Significantly, examination of BrdU incorporation indicated that mutant cells ectopically proliferated posterior to the MF, and also exhibited ectopic fj-lacZ expression (see additional file 2). Thus, whilst we do not rule out JNK-dependent effects upon the Hippo pathway in scrib mutants, our data indicates that the Hippo pathway is impaired in scrib mutant eye disc clones even when JNK signaling is blocked.
Ectopic cell proliferation, but not the loss of apico-basal cell polarity in scribmutant cells posterior to the MF, is Yki and Sd-dependent
Hippo pathway mutant defects are Yki and Sd-dependent. Loss of Yki phosphorylation results in nuclear translocation and, through association with the DNA binding protein Sd, transcriptional activation of targets including DIAP1 and CycE. Removing Yki function can rescue Hippo pathway mutant overgrowth, however, Yki is also required for normal cell proliferation in the eye disc . In contrast, Sd is largely dispensable for normal eye disc growth and proliferation and specifically mediates Hippo pathway mutant overgrowth [4, 5]. Therefore, to determine if the ectopic cell proliferation and altered cell morphology of scrib mutant cells were due to loss of Hippo pathway signaling we utilized RNAi-mediated knockdown of sd function in scrib mutant eye disc clones to look for rescue of the mutant phenotype.
scribmutant wing disc tissue overgrows through impaired Hippo signaling
Loss of lgl in the wing disc also impairs Hippo signaling, and this has been shown to depend upon JNK signaling . Indeed, as in the eye disc [38, 39], loss of scrib in the wing disc similarly led to the ectopic expression of the JNK pathway reporter msn-lacZ (Figure 4C). However, surprisingly, blocking JNK with the expression of bsk DN failed to normalize fj-lacZ expression (Figure 4D), indicating that loss of scrib in the wing disc also results in an impairment of Hippo pathway signaling that cannot be rescued by inhibiting JNK.
Having established that Hippo signaling was perturbed by scrib knockdown in the wing disc, we next wished to confirm that this was important for driving scrib mutant tissue overgrowth. Trans-heterozygous scrib 1 over scrib 3 larvae fail to pupate and form giant overgrown larvae, and whilst the eye discs do not noticeably overgrow and are reduced in size presumably due to increased cell death, the wing discs over-proliferate and become highly folded and irregular in appearance (Figure 4E). To determine if wing disc overgrowth in scrib mutants was dependent upon impaired Hippo signaling we could not remove Sd function, as was done in the eye disc, since Sd is required for normal wing disc growth through association with the wing determination factor Vestigial [42, 43]. Therefore, we utilized a yki null allele, yki B5 , to halve the gene dosage of yki in a scrib 1 /scrib 3 mutant background. Consistent with previous reports , although giant larvae were still formed throughout an extended larval phase of development, wing disc overgrowth was dramatically reduced, resulting in significantly smaller wing discs with disorganized morphology (Figure 4F). In contrast, halving the dosage of Ras85D, a gene also essential for cell growth, proliferation and viability, did not significantly reduce wing tumor size in scrib 1 /scrib 3 larvae (Figure 4G), thus implicating a key role for Yki in promoting tumor overgrowth. Furthermore, halving the gene dosage of bsk similarly failed to rescue the overgrown phenotype of the wing discs (Figure 4H), indicating that Bsk levels, unlike Yki levels, are not rate limiting for tumor overgrowth. Thus, loss of scrib in the wing disc promotes tissue overgrowth through downregulation of Hippo pathway signaling, and, as in the eye disc, this is likely to be, at least in part, independent of JNK.
Ras and Raf-driven neoplastic overgrowth of scribmutants is also Sd and Yki-dependent
Loss of scrib also promotes tumorigenesis in cooperation with oncogenic Ras signaling [reviewed in ]. In a "two hit" Drosophila tumorigenesis model we have previously shown that although scrib mutant eye clones die via JNK-mediated apoptosis, if Ras ACT or its downstream effector, Raf gof , is expressed in the mutant clones, cell death is prevented and massive and invasive tumors develop throughout an extended larval stage . To determine if downregulation of Hippo pathway signaling is also an important mediator of these overgrowths we examined the expression of the Hippo pathway reporters, ex-lacZ and fj-lacZ, in scrib - + Raf gof tumors.
The scribmutant defects in Hippo signaling are aPKC-dependent, and aPKC signaling is sufficient to impair Hippo signaling even when JNK signaling is blocked
The Scrib-aPKC polarity module is not a core component of the Hippo pathway
Although these data indicated that aPKC signaling was not important for wts or ft mutant overgrowth, it was still possible that under normal conditions, when Hippo pathway activity functions to inhibit tissue overgrowth, endogenous levels of Hippo pathway activity could be susceptible to an aPKC-mediated restraint. However, knockdown of aPKC by RNAi in both the eye disc and the wing disc did not decrease DIAP1 levels (data not shown) or reduce fj-lacZ or ex-lacZ expression, as would be expected upon hyper-activation of the Hippo pathway (see additional file 10). Furthermore, overexpression of scrib or lgl in the wing disc was also insufficient to increase Hippo pathway activation and reduce fj-lacZ or ex-lacZ expression (see additional file 10). We thus conclude that during normal tissue growth, endogenous levels of aPKC activity are not required to critically restrain Hippo pathway activity, and nor are the overexpression of scrib or lgl sufficient to ectopically activate the pathway. Thus the aPKC-Scrib polarity module does not function as a core component of the Hippo pathway, and is only likely to impinge upon Hippo signaling during specific developmental or pathological contexts.
Loss of scrib impairs Hippo pathway signaling downstream, or in parallel to, expanded and fat
Tumorigenesis may be considered as an abnormality in organogenesis and tissue regeneration, during which tissue growth is not restrained by signals that would normally function to restrict organ size. The Hippo pathway is a potent force in restraining organ overgrowth, and it is therefore logical that such a control mechanism would be perturbed during the unrestrained overgrowth of neoplasias. Indeed, in this study we show that loss of the neoplastic tumor suppressor scrib promotes tissue overgrowth through downregulation of the Hippo pathway. Furthermore, loss of scrib sensitizes cells to neoplastic transformation by Ras ACT /Raf gof , and reduced Hippo signaling cooperates with Ras-Raf to promote tumor overgrowth. Thus, impaired Hippo signaling is clearly a key force in driving scrib mutant tissue overgrowth. It is pertinent to note, however, that whilst knockdown of yki was able to completely abrogate the overgrowth of wts mutant clones (see additional file 3), it was not able to fully rescue tumor overgrowth of scrib- + Ras ACT tumors throughout an extended larval stage of development. Thus, other deregulated pathways in scrib mutants are likely to also be important for promoting tumor overgrowth. Indeed, knockdown of yki also failed to rescue the loss of apico-basal cell polarity in scrib mutants, the capacity of scrib- + Ras ACT tumor cells to invade, and the failure of the scrib- + Ras ACT tumor-bearing larvae to pupate. Although we cannot exclude the possibility that further reducing Yki activity would more effectively rescue these tumor phenotypes, the data indicate that Yki levels are not critically rate limiting for the polarity and invasive properties of scrib mutant cells.
How does scribregulate the Hippo pathway?
The impairment to Hippo signaling in scrib mutants was significantly rescued by reducing aPKC activity. As loss of scrib is also associated with aPKC-dependent apico-basal cell polarity defects, it initially seemed probable that the Hippo pathway might be affected in scrib mutants through the deregulation of apically localized Hippo pathway receptors. Indeed, in zebrafish Scrib binds to, and functionally cooperates with, Ft ; and as this interaction could be conserved in Drosophila  very direct points of intersection between Scrib and the upstream regulators of Hippo signaling can be envisaged. Our work does not rule out this possibility, and in fact, some of our data suggest that Hippo signaling is perturbed upstream of ex since ex overexpression significantly restrained scrib mutant tissue overgrowth. However, this interpretation is complicated by Ex's capacity to directly bind to, and sequester Yki activity . In fact, even ex overexpression was not sufficient to block ectopic CycE expression in scrib mutant clones, and epistasis experiments confirm that the deregulated Hippo signaling in scrib mutants is at least partially epistatic to both ex and ft, and thus downstream of two known transmembrane proteins that regulate the pathway, Crb and Ft (Figure 10). Nevertheless, despite the evidence placing scrib downstream of these proteins, there is likely to be a close relationship between Scrib's role as a cell polarity regulator and impaired Hippo signaling. Indeed, a number of recent reports indicating that increased levels of F-actin are sufficient to inhibit Hippo pathway activity [47, 48] are also suggestive, since the aPKC-dependent loss of apico-basal cell polarity in scrib mutants is often associated with F-actin accumulations (data not shown). Thus, it is possible that a number of mechanisms, including receptor mislocalization and F-actin accumulation, might be operative in driving Hippo pathway impairment when apico-basal cell polarity is disrupted in scrib mutants. Interestingly, however, lgl mutant eye disc clones are not associated with the severe alterations in cell morphology characteristic of scrib mutant cells, yet the impairment to Hippo signaling in lgl mutant clones is also dependent upon aPKC activity . Furthermore, Ex and Ft localization were unaffected in the absence of lgl, whilst both Hpo and Ras-associated domain family protein (RASSF) were co-mislocalized, consistent with the Hippo pathway being impaired downstream of Ft and Ex . Whether a common aPKC-dependent mechanism of Hippo pathway inhibition is operative in both lgl and scrib mutant eye discs will require further investigation. We note, however, that this regulation is not likely to reflect a core, rate limiting role for Scrib-Lgl in promoting, or aPKC in repressing, Hippo pathway activity since neither overexpressing Scrib or Lgl, nor knockdown of aPKC, led to significant Hippo pathway activation. Furthermore, even though the expression of an activated form of aPKC could induce the expression of Hippo pathway reporters, and thus downregulate the pathway, neither the overexpression of a wild type, membrane-tethered aPKC in eye disc clones (data not shown), nor clones of hypomorphic scrib alleles [35, and data not shown], consistently increased DIAP1 or CycE levels. The ability of cells to accommodate such wide fluctuations in Scrib, Lgl and aPKC activity suggests that aPKC-dependent Hippo pathway inhibition may only occur during specific developmental or pathological contexts during which, for instance, a threshold level is reached whereby either compromised Scrib-Lgl activity can no longer correctly localize or restrain aPKC-mediated inhibition of the pathway, or increased aPKC levels can no longer be restrained by normal levels of Scrib-Lgl. Alternative models placing Scrib-Lgl downstream of aPKC, and thus involving an aPKC-mediated impairment to Hippo pathway signaling through inhibition of Scrib-Lgl function, also remain possible and need to be considered.
The role of JNK in Hippo pathway regulation, and differences between loss of scrib and lglin the wing disc
A recent report indicates that the impaired Hippo pathway signaling in lgl mutant wing discs is dependent upon JNK signaling, and that ectopic aPKC signaling in the wing disc also acts through JNK to promote Yki activity . In the eye disc, however, we show that Hippo pathway impairment in scrib mutants, as well as upon ectopic activation of aPKC signaling, cannot be rescued by blocking JNK, and this is also likely to be the case for lgl mutants . Furthermore, in scrib mutant wing discs, although we demonstrate that JNK signaling is ectopically activated upon scrib knockdown, we also show that Hippo pathway impairment in the wing occurs, at least in part, even when JNK signaling is blocked. Why loss of scrib, unlike loss of lgl in the wing disc, does not require JNK activation to impair Hippo signaling is not yet clear. In lgl mutants, the cell polarity defects in the wing disc are also JNK-dependent , and while we did not analyze cell polarity markers upon scrib knockdown in the wing, one possibility is that loss of scrib is associated with JNK-independent cell polarity defects that impact upon the Hippo pathway in a similar manner to the eye disc. Certainly loss of scrib is notable for eliciting much stronger cell morphology defects in the eye disc than loss of lgl [39, 50]. As the cell morphology defects in scrib mutant eye disc clones are aPKC-dependent , it will be important to determine what role aPKC signaling plays in the scrib mutant wing disc phenotypes.
Although our data indicates that JNK is not required for Hippo pathway impairment in scrib mutants, it does not rule out the possibility that JNK signaling still contributes to enhance Hippo pathway deregulation. Furthermore, clearly JNK plays many other important roles in neoplastic progression, including roles in promoting invasion and a failure to pupate. Indeed, the role of JNK in neoplasia is proving to be complex, since in some contexts it functions as an oncogene to promote neoplasia, whilst in different contexts it acts as a tumor suppressor through the induction of apoptosis [38, 39, 51–53]. Its effects upon Hippo pathway regulation may therefore also be context dependent. In fact, the activation of Hippo pathway reporters in scrib mutant clones in the eye disc (in which JNK is known to be activated) were often variable, some cells clearly showing ectopic expression of DIAP1, ex-lacZ and fj-lacZ, whilst other mutant cells did not upregulate these reporters. Non-cell autonomous effects, with increased expression in wild type cells surrounding mutant clones, were also sometimes observed (data not shown), consistent with the involvement of the Hippo pathway in regenerative proliferation around dying tissue . Much of this variability appeared to be reduced when JNK signaling was blocked in the mutant clones, and whilst the rescue of some non-cell autonomous effects would be consistent with the role that JNK can play in promoting non-cell autonomous compensatory proliferation through Yki activity , it also remains possible that JNK may act in opposite ways to downregulate DIAP1 or other reporters in mutant cells destined to die. Further analysis will be required to decipher how cellular context defines the dual functions of JNK as tumor suppressor or oncogene, and how this is related to Hippo pathway regulation.
Emerging cross talk between the Hippo pathway and regulators of tissue architecture
Extensive cross talk is beginning to emerge between the Hippo pathway and regulators of cell morphology. Genes involved in controlling epithelial apico-basal cell polarity and levels of F-actin can impact upon Hippo pathway signaling, but reciprocally impaired Hippo signaling can affect cell morphology pathways. Loss of wts is capable of eliciting neoplastic overgrowth , and Hippo pathway mutants induce apical hypertrophy with increased levels of apical cell determinants such as Crb, aPKC [30, 31], and F-actin , although, interestingly, despite the potential for increased Crb, aPKC and F-actin to promote tissue hyperplasia, the overgrowth in Hippo pathway mutants is independent of the apical hypertrophy [30, 31]. This is consistent with our own work demonstrating that wts and ft mutant tissue overgrowth was independent of aPKC signaling. Furthermore, the interrelationship between Hippo and apico-basal cell polarity pathways is not confined to traditional apico-basal epithelial polarity regulators such as Scrib and aPKC, since the Hippo pathway components ft, fj and ds also participate in planar cell polarity pathways [reviewed in ], as do scrib , lgl  and aPKC [59, 60]. The emerging picture is therefore one of a complex network of interactions whereby multiple components regulating cellular architecture are employed by cells to read their position within a morphogenetic field and respond with appropriate Hippo-pathway regulated tissue growth.
In summary, this work demonstrates that loss of scrib results in epithelial tissue overgrowth in both the eye and wing discs through downregulation of the Hippo pathway. Thus Scrib joins an increasing number of epithelial apico-basal cell polarity regulators that have links with Hippo pathway control. Whether these connections are operative in mammals is not yet clear, however, both the Hippo organ size control and Scribble cell polarity function are highly conserved. Loss of Hippo pathway signaling or ectopic activation of the Yki or Sd homologues, (YAP and TEAD family proteins respectively), is emerging as a powerful oncogenic force [reviewed in ]. Similarly, the mammalian Scrib module is increasingly implicated in tumorigenesis [reviewed in ], and mammalian Scrib can restrain tissue transformation by oncogenic Ras , and Myc . Mammalian Scrib also functions within planar cell polarity pathways , and although links with the Hippo pathway have not yet been described, the connection is likely to be conserved since studies in the zebrafish indicate that zScrib binds to zFat1 and also promotes Hippo pathway activation . The uniting of these two powerful tumor suppressor pathways clearly has important implications for human carcinogenesis. Loss of apico-basal cell polarity is considered to be a critical hallmark of neoplastic transformation, and it will be important to determine if in mammalian cancer this is also associated with defective Hippo signaling and subsequent tumor overgrowth.
The following Drosophila stocks were used: ey-FLP1, UAS-mCD8-GFP;;Tub-GAL4, FRT82B, Tub-GAL80 ; y, w, hs-FLP; FRT82B, Ubi-GFP; en-GAL4; UAS-DaPKC ΔN ; UAS-DaPKC CAAXDN ; UAS- aPKC RNAi (VDRC #2907); bsk 2 ; UAS-bsk DN ; UAS-bsk RNAi (NIG #5680R-1); d 1 ; d GC13 ; ex e1 ; ex 697 (ex-lacZ in all figures except Figure 9J which is ex e1 ) ; UAS-ex ; ft fd ; UAS-ft RNAi (VDRC #9396); fj-lacZ ; UAS-lgl 5.1 ; UAS-lgl 3A ; UAS-phl gof (UAS-Raf gof ) ; Ras85D e1b ; UAS-dRas1 V12 ; UAS-scrib 19.2 ; FRT82B, scrib 1 ; scrib 3 ; UAS-scrib RNAi (VDRC #27424); UAS-sd RNAi (NIG #8544R-2); wts X1 ; UAS-wts RNAi (NIG #12072R-1); yki B5 ; UAS-yki RNAi .
Clonal analysis utilized either MARCM (mosaic analysis with repressible cell marker)  with FRT82B and ey-FLP1 to induce clones and mCD8-GFP expression to mark mutant tissue, or for negatively marked scrib 1 clones, hs-FLP with FRT82B, Ubi-GFP. All fly crosses were carried out at 25°C and grown on standard fly media. Heat shock clones were induced by a temperature shift to 37°C for 15 minutes, and discs were harvested at 64 hours after clone induction. For the examination of scrib 1 clones in a d mutant background, hs-FLP induced FRT82B, scrib 1 clones were generated in a d 1 /d GC13 , ex 697 , FRT40A mutant background. For the examination of scrib 1 clones in a ft ex double mutant background, hs-FLP induced FRT82B, scrib 1 clones were generated in a ft fd , ex e1 , FRT40A homozygous mutant background.
Imaginal discs were dissected in phosphate-buffered saline (PBS) from either wandering 3rd instar larvae or from staged lays of larvae for genotypes which failed to pupate and entered an extended larval stage of development. Tissues were fixed in 4% formaldehyde in PBS, and blocked in 2% goat serum in PBT (PBS 0.1% Triton X-100). For the detection of S phase cells, a 1 h BrdU pulse at 25°C was followed by fixation, immuno-detection of GFP, further fixation, acid treatment and immuno-detection of the BrdU epitope. Primary antibodies were incubated with the samples in block overnight at 4°C, and were used at the following concentrations; mouse anti-β-galactosidase (Rockland) at 1 in 400, mouse anti-Elav (Developmental Studies Hybridoma Bank) at 1 in 20, rat anti-Cyclin E (Helen McNeill) at 1 in 400, mouse anti-DIAP1 (Bruce Hay) at 1 in 100, rabbit anti-GFP (Invitrogen) at 1 in 1000, mouse anti-BrdU (Becton-Dickinson) at 1 in 50. Secondary antibodies used were; anti-mouse/rat Alexa647 (Invitrogen) and anti-rabbit Alexa488 (Invitrogen) at 1 in 400. F-actin was detected with phalloidin-tetramethylrhodamine isothiocyanate (TRITC; Sigma, 0.3 μM) at 1 in 1000. Samples were mounted in 80% glycerol.
Microscopy and image processing
All samples were analyzed by confocal microscopy on an Olympus FV1000 microscope. Single optical sections were selected in Flouroview® software before being processed in Adobe Photoshop®CS2 and assembled into figures in Adobe Illustrator®CS2.
List of Abbreviations
atypical protein kinase C
bovine serum albumin
Drosophila inhibitor of apoptosis 1
flippase recognition target
Jun N-terminal kinase
lethal giant larvae
mosaic analysis with repressible marker
We thank Linda Parsons, Kieran Harvey and Patrick Humbert for helpful discussions, Greg Leong for technical help with the initial experiments looking at DIAP1 levels in scrib mutants, Barry Dickson for supplying the scrib RNAi transgenic flies, and D. Bilder, S. Campuzano, K. Harvey, B. Hay, J. Jiang, J. Knoblich, H. McNeill, J. Treisman, the Bloomington Stock Centre, the Vienna Drosophila RNAi Centre (VDRC), the National Institute of Genetics (NIG) Fly Stock Centre and the Developmental Studies Hybridoma Bank for contributing fly stocks and/or reagents. This work was supported by grants from the Australian National Health and Medical Research Council (NHMRC) to AMB (NHMRC Grant#350396 and Grant#509051) and HER (NHMRC Senior research Fellowship B and NHMRC Grants). FG was the recipient of a Melbourne International Research scholarship and Melbourne International Fee Remission Scholarship from the University of Melbourne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
- Brumby AM, Richardson HE: Using Drosophila melanogaster to map human cancer pathways. Nat Rev Cancer. 2005, 5: 626-39. 10.1038/nrc1671.View ArticlePubMed
- Hariharan IK, Bilder D: Regulation of imaginal disc growth by tumor-suppressor genes in Drosophila. Annu Rev Genet. 2006, 40: 335-61. 10.1146/annurev.genet.39.073003.100738.View ArticlePubMed
- Harvey K, Tapon N: The Salvador-Warts-Hippo pathway - an emerging tumor-suppressor network. Nat Rev Cancer. 2007, 7: 182-91. 10.1038/nrc2070.View ArticlePubMed
- Wu S, Liu Y, Zheng Y, Dong J, Pan D: The TEAD/TEF family protein Scalloped mediates transcriptional output of the Hippo growth-regulatory pathway. Dev Cell. 2008, 14: 388-98. 10.1016/j.devcel.2008.01.007.View ArticlePubMed
- Zhang L, Ren F, Zhang Q, Chen Y, Wang B, Jiang J: The TEAD/TEF family of transcription factor Scalloped mediates Hippo signaling in organ size control. Dev Cell. 2008, 14: 377-87. 10.1016/j.devcel.2008.01.006.PubMed CentralView ArticlePubMed
- Goulev Y, Fauny JD, Gonzalez-Marti B, Flagiello D, Silber J, Zider A: SCALLOPED interacts with YORKIE, the nuclear effector of the hippo tumor-suppressor pathway in Drosophila. Curr Biol. 2008, 18: 435-41. 10.1016/j.cub.2008.02.034.View ArticlePubMed
- Huang J, Wu S, Barrera J, Matthews K, Pan D: The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila Homolog of YAP. Cell. 2005, 122: 421-34. 10.1016/j.cell.2005.06.007.View ArticlePubMed
- Dong J, Feldmann G, Huang J, Wu S, Zhang N, Comerford SA, Gayyed MF, Anders RA, Maitra A, Pan D: Elucidation of a universal size-control mechanism in Drosophila and mammals. Cell. 2007, 130: 1120-33. 10.1016/j.cell.2007.07.019.PubMed CentralView ArticlePubMed
- Oh H, Irvine KD: In vivo regulation of Yorkie phosphorylation and localization. Development. 2008, 135: 1081-8. 10.1242/dev.015255.PubMed CentralView ArticlePubMed
- Neto-Silva RM, de Beco S, Johnston LA: Evidence for a growth-stabilizing regulatory feedback mechanism between Myc and Yorkie, the Drosophila homolog of Yap. Dev Cell. 2010, 19: 507-20. 10.1016/j.devcel.2010.09.009.PubMed CentralView ArticlePubMed
- Ziosi M, Baena-Lopez LA, Grifoni D, Froldi F, Pession A, Garoia F, Trotta V, Bellosta P, Cavicchi S, Pession A: dMyc functions downstream of Yorkie to promote the supercompetitive behavior of hippo pathway mutant cells. PLoS Genet. 2010, 6: e1001140-10.1371/journal.pgen.1001140.PubMed CentralView ArticlePubMed
- Mao Y, Rauskolb C, Cho E, Hu WL, Hayter H, Minihan G, Katz FN, Irvine KD: Dachs: an unconventional myosin that functions downstream of Fat to regulate growth, affinity and gene expression in Drosophila. Development. 2006, 133: 2539-51. 10.1242/dev.02427.View ArticlePubMed
- Tyler DM, Baker NE: Expanded and fat regulate growth and differentiation in the Drosophila eye through multiple signaling pathways. Dev Biol. 2007, 305: 187-201. 10.1016/j.ydbio.2007.02.004.PubMed CentralView ArticlePubMed
- Willecke M, Hamaratoglu F, Kango-Singh M, Udan R, Chen CL, Tao C, Zhang X, Halder G: The fat cadherin acts through the hippo tumor-suppressor pathway to regulate tissue size. Curr Biol. 2006, 16: 2090-100. 10.1016/j.cub.2006.09.005.View ArticlePubMed
- Silva E, Tsatskis Y, Gardano L, Tapon N, McNeill H: The tumor-suppressor gene fat controls tissue growth upstream of expanded in the hippo signaling pathway. Curr Biol. 2006, 16: 2081-9. 10.1016/j.cub.2006.09.004.View ArticlePubMed
- Feng Y, Irvine KD: Fat and expanded act in parallel to regulate growth through warts. Proc Natl Acad Sci USA. 2007, 104: 20362-7. 10.1073/pnas.0706722105.PubMed CentralView ArticlePubMed
- Hamaratoglu F, Willecke M, Kango-Singh M, Nolo R, Hyun E, Tao C, Jafar-Nejad H, Halder G: The tumor-suppressor genes NF2/Merlin and Expanded act through Hippo signaling to regulate cell proliferation and apoptosis. Nat Cell Biol. 2006, 8: 27-36. 10.1038/ncb1339.View ArticlePubMed
- Pellock BJ, Buff E, White K, Hariharan IK: The Drosophila tumor suppressors Expanded and Merlin differentially regulate cell cycle exit, apoptosis, and Wingless signaling. Dev Biol. 2007, 304: 102-15. 10.1016/j.ydbio.2006.12.021.PubMed CentralView ArticlePubMed
- Bennett FC, Harvey KF: Fat cadherin modulates organ size in Drosophila via the Salvador/Warts/Hippo signaling pathway. Curr Biol. 2006, 16: 2101-10. 10.1016/j.cub.2006.09.045.View ArticlePubMed
- Rogulja D, Rauskolb C, Irvine KD: Morphogen control of wing growth through the Fat signaling pathway. Dev Cell. 2008, 15: 309-21. 10.1016/j.devcel.2008.06.003.PubMed CentralView ArticlePubMed
- Zhao B, Lei QY, Guan KL: The Hippo-YAP pathway: new connections between regulation of organ size and cancer. Curr Opin Cell Biol. 2008, 20: 638-46. 10.1016/j.ceb.2008.10.001.PubMed CentralView ArticlePubMed
- Vaccari T, Bilder D: At the crossroads of polarity, proliferation and apoptosis: The use of Drosophila to unravel the multifaceted role of endocytosis in tumor suppression. Mol Oncol. 2009, 3: 354-65. 10.1016/j.molonc.2009.05.005.PubMed CentralView ArticlePubMed
- Lu H, Bilder D: Endocytic control of epithelial polarity and proliferation in Drosophila. Nat Cell Biol. 2005, 7: 1232-9.View ArticlePubMed
- Rolls MM, Albertson R, Shih HP, Lee CY, Doe CQ: Drosophila aPKC regulates cell polarity and cell proliferation in neuroblasts and epithelia. J Cell Biol. 2003, 163: 1089-98. 10.1083/jcb.200306079.PubMed CentralView ArticlePubMed
- Gilbert MM, Robinson BS, Moberg KH: Functional interactions between the erupted/tsg101 growth suppressor gene and the DaPKC and rbf1 genes in Drosophila imaginal disc tumors. PLoS One. 2009, 4: e7039-10.1371/journal.pone.0007039.PubMed CentralView ArticlePubMed
- Betschinger J, Mechtler K, Knoblich JA: The Par complex directs asymmetric cell division by phosphorylating the cytoskeletal protein Lgl. Nature. 2003, 422: 326-30. 10.1038/nature01486.View ArticlePubMed
- Wirtz-Peitz F, Nishimura T, Knoblich JA: Linking cell cycle to asymmetric division: Aurora-A phosphorylates the Par complex to regulate Numb localization. Cell. 2008, 135: 161-73. 10.1016/j.cell.2008.07.049.PubMed CentralView ArticlePubMed
- Humbert PO, Grzeschik NA, Brumby AM, Galea R, Elsum I, Richardson HE: Control of tumorigenesis by the Scribble/Dlg/Lgl polarity module. Oncogene. 2008, 27: 6888-907. 10.1038/onc.2008.341.View ArticlePubMed
- Justice RW, Zilian O, Woods DF, Noll M, Bryant PJ: The Drosophila tumor suppressor gene warts encodes a homolog of human myotonic dystrophy kinase and is required for the control of cell shape and proliferation. Genes Dev. 1995, 9: 534-46. 10.1101/gad.9.5.534.View ArticlePubMed
- Hamaratoglu F, Gajewski K, Sansores-Garcia L, Morrison C, Tao C, Halder G: The Hippo tumor-suppressor pathway regulates apical-domain size in parallel to tissue growth. J Cell Sci. 2009, 122: 2351-9. 10.1242/jcs.046482.PubMed CentralView ArticlePubMed
- Genevet A, Polesello C, Blight K, Robertson F, Collinson LM, Pichaud F, Tapon N: The Hippo pathway regulates apical-domain size independently of its growth-control function. J Cell Sci. 2009, 122: 2360-70. 10.1242/jcs.041806.PubMed CentralView ArticlePubMed
- Ling C, Zheng Y, Yin F, Yu J, Huang J, Hong Y, Wu S, Pan D: The apical transmembrane protein Crumbs functions as a tumor suppressor that regulates Hippo signaling by binding to Expanded. Proc Natl Acad Sci USA. 2010, 107: 10532-7. 10.1073/pnas.1004279107.PubMed CentralView ArticlePubMed
- Chen CL, Gajewski KM, Hamaratoglu F, Bossuyt W, Sansores-Garcia L, Tao C, Halder G: The apical-basal cell polarity determinant Crumbs regulates Hippo signaling in Drosophila. Proc Natl Acad Sci USA . 2010, 107: 15810-5. 10.1073/pnas.1004060107.PubMed CentralView ArticlePubMed
- Robinson BS, Huang J, Hong Y, Moberg KH: Crumbs regulates Salvador/Warts/Hippo signaling in Drosophila via the FERM-domain protein Expanded. Curr Biol. 2010, 20: 582-90. 10.1016/j.cub.2010.03.019.PubMed CentralView ArticlePubMed
- Grzeschik NA, Parsons LM, Allott ML, Harvey KF, Richardson HE: Lgl, aPKC, and Crumbs regulate the Salvador/Warts/Hippo pathway through two distinct mechanisms. Curr Biol. 2010, 20: 573-81. 10.1016/j.cub.2010.01.055.View ArticlePubMed
- Zhao M, Szafranski P, Hall CA, Goode S: Basolateral junctions utilize warts signaling to control epithelial-mesenchymal transition and proliferation crucial for migration and invasion of Drosophila ovarian epithelial cells. Genetics. 2008, 178: 1947-71. 10.1534/genetics.108.086983.PubMed CentralView ArticlePubMed
- Sun G, Irvine KD: Regulation of Hippo signaling by Jun kinase signaling during compensatory cell proliferation and regeneration, and in neoplastic tumors. Dev Biol. 2011, 350: 139-51. 10.1016/j.ydbio.2010.11.036.PubMed CentralView ArticlePubMed
- Leong GR, Goulding KR, Amin N, Richardson HE, Brumby AM: Scribble mutants promote aPKC and JNK-dependent epithelial neoplasia independently of Crumbs. BMC Biol. 2009, 7: 62-10.1186/1741-7007-7-62.PubMed CentralView ArticlePubMed
- Brumby AM, Richardson HE: scribble mutants cooperate with oncogenic Ras or Notch to cause neoplastic overgrowth in Drosophila. Embo J. 2003, 22: 5769-79. 10.1093/emboj/cdg548.PubMed CentralView ArticlePubMed
- Tapon N, Harvey KF, Bell DW, Wahrer DC, Schiripo TA, Haber DA, Hariharan IK: salvador Promotes both cell cycle exit and apoptosis in Drosophila and is mutated in human cancer cell lines. Cell. 2002, 110: 467-78. 10.1016/S0092-8674(02)00824-3.View ArticlePubMed
- Cho E, Feng Y, Rauskolb C, Maitra S, Fehon R, Irvine KD: Delineation of a Fat tumor suppressor pathway. Nat Genet. 2006, 38: 1142-50. 10.1038/ng1887.View ArticlePubMed
- Halder G, Polaczyk P, Kraus ME, Hudson A, Kim J, Laughon A, Carroll S: The Vestigial and Scalloped proteins act together to directly regulate wing-specific gene expression in Drosophila. Genes Dev. 1998, 12: 3900-9. 10.1101/gad.12.24.3900.PubMed CentralView ArticlePubMed
- Simmonds AJ, Liu X, Soanes KH, Krause HM, Irvine KD, Bell JB: Molecular interactions between Vestigial and Scalloped promote wing formation in Drosophila. Genes Dev. 1998, 12: 3815-20. 10.1101/gad.12.24.3815.PubMed CentralView ArticlePubMed
- Grusche FA, Richardson HE, Harvey KF: Upstream regulation of the hippo size control pathway. Curr Biol. 2010, 20: R574-82. 10.1016/j.cub.2010.05.023.View ArticlePubMed
- Skouloudaki K, Puetz M, Simons M, Courbard JR, Boehlke C, Hartleben B, Engel C, Moeller MJ, Englert C, Bollig F, et al: Scribble participates in Hippo signaling and is required for normal zebrafish pronephros development. Proc Natl Acad Sci USA. 2009, 106: 8579-84. 10.1073/pnas.0811691106.PubMed CentralView ArticlePubMed
- Badouel C, Gardano L, Amin N, Garg A, Rosenfeld R, Le Bihan T, McNeill H: The FERM-domain protein Expanded regulates Hippo pathway activity via direct interactions with the transcriptional activator Yorkie. Dev Cell. 2009, 16: 411-20. 10.1016/j.devcel.2009.01.010.View ArticlePubMed
- Sansores-Garcia L, Bossuyt W, Wada K, Yonemura S, Tao C, Sasaki H, Halder G: Modulating F-actin organization induces organ growth by affecting the Hippo pathway. Embo J. 2011, 30: 2325-35. 10.1038/emboj.2011.157.PubMed CentralView ArticlePubMed
- Fernandez BG, Gaspar P, Bras-Pereira C, Jezowska B, Rebelo SR, Janody F: Actin-Capping Protein and the Hippo pathway regulate F-actin and tissue growth in Drosophila. Development. 2011, 138: 2337-46. 10.1242/dev.063545.View ArticlePubMed
- Grzeschik NA, Parsons LM, Richardson HE: Lgl, the SWH pathway and tumorigenesis: It's a matter of context & competition!. Cell Cycle. 2010, 9: 3202-12. 10.4161/cc.9.16.12633.View ArticlePubMed
- Grzeschik NA, Amin N, Secombe J, Brumby AM, Richardson HE: Abnormalities in cell proliferation and apico-basal cell polarity are separable in Drosophila lgl mutant clones in the developing eye. Dev Biol. 2007, 311: 106-23. 10.1016/j.ydbio.2007.08.025.PubMed CentralView ArticlePubMed
- Igaki T, Pagliarini RA, Xu T: Loss of cell polarity drives tumor growth and invasion through JNK activation in Drosophila. Curr Biol. 2006, 16: 1139-46. 10.1016/j.cub.2006.04.042.View ArticlePubMed
- Uhlirova M, Bohmann D: JNK- and Fos-regulated Mmp1 expression cooperates with Ras to induce invasive tumors in Drosophila. Embo J. 2006, 25: 5294-304. 10.1038/sj.emboj.7601401.PubMed CentralView ArticlePubMed
- Brumby AM, Goulding KR, Schlosser T, Loi S, Galea R, Khoo P, Bolden JE, Aigaki T, Humbert PO, Richardson HE: Identification of novel Ras-cooperating oncogenes in Drosophila melanogaster: a RhoGEF/Rho-family/JNK pathway is a central driver of tumorigenesis. Genetics. 2011, 188: 105-25. 10.1534/genetics.111.127910.PubMed CentralView ArticlePubMed
- Grusche FA, Degoutin JL, Richardson HE, Harvey KF: The Salvador/Warts/Hippo pathway controls regenerative tissue growth in Drosophila melanogaster. Dev Biol. 2011, 350: 255-66. 10.1016/j.ydbio.2010.11.020.View ArticlePubMed
- Menut L, Vaccari T, Dionne H, Hill J, Wu G, Bilder D: A mosaic genetic screen for Drosophila neoplastic tumor suppressor genes based on defective pupation. Genetics. 2007, 177: 1667-77. 10.1534/genetics.107.078360.PubMed CentralView ArticlePubMed
- Seifert JR, Mlodzik M: Frizzled/PCP signaling: a conserved mechanism regulating cell polarity and directed motility. Nat Rev Genet. 2007, 8: 126-38.View ArticlePubMed
- Courbard JR, Djiane A, Wu J, Mlodzik M: The apical/basal-polarity determinant Scribble cooperates with the PCP core factor Stbm/Vang and functions as one of its effectors. Dev Biol. 2009, 333: 67-77. 10.1016/j.ydbio.2009.06.024.PubMed CentralView ArticlePubMed
- Dollar GL, Weber U, Mlodzik M, Sokol SY: Regulation of Lethal giant larvae by Dishevelled. Nature. 2005, 437: 1376-80. 10.1038/nature04116.View ArticlePubMed
- Djiane A, Yogev S, Mlodzik M: The apical determinants aPKC and dPatj regulate Frizzled-dependent planar cell polarity in the Drosophila eye. Cell. 2005, 121: 621-31. 10.1016/j.cell.2005.03.014.View ArticlePubMed
- Harris TJ, Peifer M: aPKC controls microtubule organization to balance adherens junction symmetry and planar polarity during development. Dev Cell. 2007, 12: 727-38. 10.1016/j.devcel.2007.02.011.PubMed CentralView ArticlePubMed
- Dow LE, Elsum IA, King CL, Kinross KM, Richardson HE, Humbert PO: Loss of human Scribble cooperates with H-Ras to promote cell invasion through deregulation of MAPK signaling. Oncogene. 2008, 27: 5988-6001. 10.1038/onc.2008.219.View ArticlePubMed
- Zhan L, Rosenberg A, Bergami KC, Yu M, Xuan Z, Jaffe AB, Allred C, Muthuswamy SK: Deregulation of scribble promotes mammary tumorigenesis and reveals a role for cell polarity in carcinoma. Cell. 2008, 135: 865-78. 10.1016/j.cell.2008.09.045.PubMed CentralView ArticlePubMed
- Montcouquiol M, Rachel RA, Lanford PJ, Copeland NG, Jenkins NA, Kelley MW: Identification of Vangl2 and Scrb1 as planar polarity genes in mammals. Nature. 2003, 423: 173-7. 10.1038/nature01618.View ArticlePubMed
- Lee JD, Treisman JE: The role of Wingless signaling in establishing the anteroposterior and dorsoventral axes of the eye disc. Development. 2001, 128: 1519-29.PubMed
- Sotillos S, Diaz-Meco MT, Caminero E, Moscat J, Campuzano S: DaPKC-dependent phosphorylation of Crumbs is required for epithelial cell polarity in Drosophila. J Cell Biol. 2004
- Riesgo-Escovar JR, Jenni M, Fritz A, Hafen E: The Drosophila Jun-N-terminal kinase is required for cell morphogenesis but not for DJun-dependent cell fate specification in the eye. Genes Dev. 1996, 10: 2759-68. 10.1101/gad.10.21.2759.View ArticlePubMed
- Adachi-Yamada T, Nakamura M, Irie K, Tomoyasu Y, Sano Y, Mori E, Goto S, Ueno N, Nishida Y, Matsumoto K: p38 mitogen-activated protein kinase can be involved in transforming growth factor beta superfamily signal transduction in Drosophila wing morphogenesis. Mol Cell Biol. 1999, 19: 2322-9.PubMed CentralView ArticlePubMed
- Buckles GR, Rauskolb C, Villano JL, Katz FN: Four-jointed interacts with dachs, abelson and enabled and feeds back onto the Notch pathway to affect growth and segmentation in the Drosophila leg. Development. 2001, 128: 3533-42.PubMed
- Boedigheimer M, Laughon A: Expanded: a gene involved in the control of cell proliferation in imaginal discs. Development. 1993, 118: 1291-301.PubMed
- Boedigheimer MJ, Nguyen KP, Bryant PJ: Expanded functions in the apical cell domain to regulate the growth rate of imaginal discs. Dev Genet. 1997, 20: 103-10. 10.1002/(SICI)1520-6408(1997)20:2<103::AID-DVG3>3.0.CO;2-B.View ArticlePubMed
- Bryant PJ, Huettner B, Held LI, Ryerse J, Szidonya J: Mutations at the fat locus interfere with cell proliferation control and epithelial morphogenesis in Drosophila. Dev Biol. 1988, 129: 541-54. 10.1016/0012-1606(88)90399-5.View ArticlePubMed
- Brodsky MH, Steller H: Positional information along the dorsal-ventral axis of the Drosophila eye: graded expression of the four-jointed gene. Dev Biol. 1996, 173: 428-46. 10.1006/dbio.1996.0038.View ArticlePubMed
- Brand AH, Perrimon N: Raf acts downstream of the EGF receptor to determine dorsoventral polarity during Drosophila oogenesis. Genes Dev. 1994, 8: 629-39. 10.1101/gad.8.5.629.View ArticlePubMed
- Simon MA, Bowtell DD, Dodson GS, Laverty TR, Rubin GM: Ras1 and a putative guanine nucleotide exchange factor perform crucial steps in signaling by the sevenless protein tyrosine kinase. Cell. 1991, 67: 701-16. 10.1016/0092-8674(91)90065-7.View ArticlePubMed
- Karim FD, Rubin GM: Ectopic expression of activated Ras1 induces hyperplastic growth and increased cell death in Drosophila imaginal tissues. Development. 1998, 125: 1-9.PubMed
- Bilder D, Perrimon N: Localization of apical epithelial determinants by the basolateral PDZ protein Scribble. Nature. 2000, 403: 676-80. 10.1038/35001108.View ArticlePubMed
- Zeitler J, Hsu CP, Dionne H, Bilder D: Domains controlling cell polarity and proliferation in the Drosophila tumor suppressor Scribble. J Cell Biol. 2004, 167: 1137-46. 10.1083/jcb.200407158.PubMed CentralView ArticlePubMed
- Xu T, Wang W, Zhang S, Stewart RA, Yu W: Identifying tumor suppressors in genetic mosaics: the Drosophila lats gene encodes a putative protein kinase. Development. 1995, 121: 1053-63.PubMed
- Lee T, Luo L: Mosaic analysis with a repressible cell marker for studies of gene function in neuronal morphogenesis. Neuron. 1999, 22: 451-61. 10.1016/S0896-6273(00)80701-1.View ArticlePubMed
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.